EN DE

Blonder Tongue Laboratories, Inc. (BDRLQ) Fair Value & Analysis

Technology · US · Market cap $5.8K

BT Blonder Tongue Laboratories, Inc. logo Blonder Tongue Laboratories, Inc. BDRLQ · US
Price$0.0002
Fair Value$0.0002
Upside+0.0%
Quality53/100
Watch Blonder Tongue Laboratories, Inc. for free, get notified when fair value or trend changes. Watch for free
Weak Growth
Loss-making · -16.1% net margin
Negative equity (buybacks among others) · generates free cash flow
Mixed vs. peers (5/9)
Narrow moat 12/100
Evidence: Medium Range $0.0002 – $0.0002 Share as image

Fair value as of: Aug 13, 2026

From 9 valuation models · updated 4 days ago

A solid business, currently priced close to our fair value.

Fair value for all 35,000+ stocks, review alerts and the diversification check: 14 days of Pro free, no card.

What matters now

  • The price sits close to our fair value, market and models broadly agree here, little valuation tension.
  • Our model range runs from $0.0002 (bear) to $0.0002 (bull), base $0.0002. The closer the price sits to the lower half, the larger the margin of safety.
  • Quality 53/100 (solid quality) with medium evidence: read the verdict with care.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$2.22 $0.0001 Fair Value $0.0002 Jun 2020 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

60‑month range $0.0001 – $2.22 · the $0.0002 price screens below the $0.0002 fair value. Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Blonder Tongue Laboratories, Inc. (BDRLQ) currently trades at $0.0002, while our model-based Fair Value estimate is $0.0002, implying the stock looks roughly 0.0% fairly valued today. The Quality Score stands at 53/100 (solid quality), in the Technology sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.

Over the trailing twelve months, Blonder Tongue Laboratories, Inc. generated revenue of $18.1M at a net margin of -16.1%. Revenue grew 32.2% year over year. Net debt stands at $8.1M. Fundamentals as of Aug 13, 2026

For context, the median of 10 Technology peers we cover trades at -50% fair-value upside, at 0%, BDRLQ screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF $0.0013 $0.0017 $0.0023 80
Rev-Margin DCF $0.0014 $0.0023 $0.0033 74
EV/EBITDA $0.0002 $0.0004 54
All 9 models by family
DCF Models
FCF DCF $0.0013 $0.0017 $0.0024 38
5Y Revenue Exit $0.0014 $0.0022 $0.0034 39
5Y EBITDA Exit $0.0006 $0.0008 $0.0011 41
10Y Revenue Exit $0.0013 $0.0018 $0.0024 36
10Y EBITDA Exit $0.0009 $0.0011 $0.0012 37
Multiples
EV/EBITDA $0.0002 $0.0004 54
EV/Revenue $0.0017 $0.0026 $0.0036 43
Growth DCF
Growth DCF $0.0013 $0.0017 $0.0023 80
Rev-Margin DCF $0.0014 $0.0023 $0.0033 74

Widest divergence: DCF Models ($0.0017) versus Multiples ($0.0002). Highest evidence: Growth DCF (80).

Notify me when BDRLQ reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) $18.1M
Revenue growth (YoY) +32.2%
Net margin -16.1%
Return on equity -134%
Free cash flow $1.0M FY2024
Operating margin 6.2%
More key figures
EPS (TTM) $-0.0900
Net debt $8.1M FY2024

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 53/100

Of which business quality 52 · Market factors (momentum, volatility) 15

Profitability 40
Margins and returns on capital today
Quality Growth 68
Are margins and returns improving?
Cashflow 63
Earnings quality: real cash, not paper profit
Fin. Strength 0
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 0
Price trend over the last 3–12 months (market factor)
52W Momentum 0
Distance to the 52-week high (market factor)
Net Issuance 74
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Blonder Tongue Laboratories, Inc., a technology-development and manufacturing company, provides television (TV) signal encoding, transcoding, digital transport, and broadband product solutions in the United States. It offers NXG modular IP video systems, CV transcoders, CV encoders, Aircaster off-air series, and the DRAKE series.

Full company description

Blonder Tongue Laboratories, Inc., a technology-development and manufacturing company, provides television (TV) signal encoding, transcoding, digital transport, and broadband product solutions in the United States. It offers NXG modular IP video systems, CV transcoders, CV encoders, Aircaster off-air series, and the DRAKE series. The company also provides video encoding and transcoding, analog modulators, receivers and modulators, data over cable service interface specification-cable modem termination systems, fiber optics, broadband amplifiers, test and measurement products, passives, and accessories. In addition, it provides end-of-life CableCARD solutions, secure reliable transport solutions, and local content solutions for hospitality networks. Blonder Tongue Laboratories, Inc. was founded in 1950 and is based in Old Bridge, New Jersey.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2020 – FY2024 · reported fiscal years

Blonder Tongue Laboratories, Inc. reported revenue of $11.2M in FY2024 versus $16.4M in FY2020, a compound −9.1%/yr. Reported net income was −$1.2M in FY2024.

Growth Quality 15/100
Revenue growth is weak, negative or inconsistent.
Latest Revenue (FY 2024)
$11.2M
Latest YoY
−15.5%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−10.8%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−10.9%
Avg. growth/yr (29Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−5.2%
Revenue −9.1%/yr
FY20 $16.4M
FY21 $15.8M
FY22 $18.1M
FY23 $13.2M
FY24 $11.2M
Net income
FY20 −$7.5M
FY21 $84.0K
FY22 −$2.9M
FY23 −$2.1M
FY24 −$1.2M

Watch BDRLQ: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Blonder Tongue Laboratories, Inc. Fair Value". https://www.fairvalue-calculator.com/stock/BDRLQ

Peer Group

Communication Equipment · 300 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 53 · Below median
Fair Value upside +0% · Above median
Return on assets -10% · Bottom 25%
Net margin (TTM) -16% · Bottom 25%
Operating margin (TTM) 6% · Above median
Revenue growth 32% · Top 25%

Valuation Multiples vs Communication Equipment median · lower = cheaper

P/FCF 0.0× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 33 · sector 0
FUTURE 100 · sector 36
PAST 0 · sector 15
HEALTH 100 · sector 98
DIVIDEND 0 · sector 24

PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Communication Equipment stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Stock Price Fair Value vs Fair Value
Cisco Systems, Inc CSCO $120.43 $61.53 -49%
Zhongji Innolight Co 300308 ¥921.00 ¥171.09 -81%
Foxconn Industrial Internet Co 601138 ¥65.60 ¥28.65 -56%
Eoptolink Technology Inc 300502 ¥429.90 ¥176.99 -59%
Nokia Oyj NOK $10.32 $3.77 -63%
Motorola Solutions, Inc MSI $469.74 $236.33 -50%
Suzhou TFC Optical Communication Co 300394 ¥240.05 ¥43.67 -82%
Accton Technology Corporation 2345 2,270 TWD 1,135 TWD -50%
Telefonaktiebolaget LM Ericsson (publ), ERICB kr 97.78 kr 157.82 +61%
ZTE Corporation 000063 ¥35.59 ¥19.72 -45%

Compare Blonder Tongue Laboratories, Inc. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Blonder Tongue Laboratories, Inc. (BDRLQ) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of $0.0002 versus a price of $0.0002, about +0% (fairly valued).
What is the fair value of BDRLQ?
Our model-based fair value for Blonder Tongue Laboratories, Inc. is $0.0002 (as of Aug 13, 2026), built from audited fundamentals. The current price is $0.0002.
What is the quality score of BDRLQ?
Blonder Tongue Laboratories, Inc. has a Quality Score of 53/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Blonder Tongue Laboratories, Inc. (BDRLQ)?
Blonder Tongue Laboratories, Inc. reported trailing-twelve-month revenue of about $18.1M (latest available figure, as of Aug 13, 2026).
What is the net profit margin of BDRLQ?
The net profit margin of Blonder Tongue Laboratories, Inc. is about -16.1%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Blonder Tongue Laboratories, Inc. and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.